Impact of Patient Characteristics on the Outcomes of Patients with Gastrointestinal Cancers Treated with Immune Checkpoint Inhibitors

Gastrointestinal (GI) cancers are a group of malignancies that globally account for a significant portion of cancer incidence and cancer-related death. Survival outcomes for esophageal, gastric, pancreatic, and hepatobiliary cancers remain poor, but new treatment paradigms are emerging with the adve...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohm, Hyejee, Abdel-Rahman, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858132/
https://www.ncbi.nlm.nih.gov/pubmed/36661709
http://dx.doi.org/10.3390/curroncol30010060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858132/
https://www.ncbi.nlm.nih.gov/pubmed/36661709
http://dx.doi.org/10.3390/curroncol30010060

Ejemplares similares